The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Firstly Crumbs for what its worth I would also like both you and Berm to continue on this BB !!!
Secondly in your last post you state"One partial response that has gone progressive out of 24 fully dosed patients most of whom are no longer on trial does not read commercial to me seeing as tumor reduction was what modi was all about and is the gold standard of success (personal opinion that)... better to shift focus to SCIB1 like Scancell are doing "
And yet yesterday in the RNS Lindy states
"As communicated at the time of the recent business update, our strategic focus is on the continued development of the Company's two lead clinical assets SCIB1 and Modi-1."
It would appear Modi 1 is still presently very much considered commercially viable !!!!
Amazon France translation :-
Temporarily out of stock due to high demand.
We are doing everything possible to make this item available to you as soon as possible. Order and we will contact you by e-mail when we have an estimated delivery date.
It would appear demand is outstripping supply
Hi Crumbs like you I share your frustration 15yrs worth.......but lets suppose your right and Lindy is the problem I believe she is aware of her shortcomings on the business side of things hence Cossèry's arrival the calibre of which is in no doubt and certainly not here to continue in the RG "potting shed". Then we have the arrival of a CBO in Sept who I believe Cossèry was instrumental in finding and filling that position and didn't he say it was "tricky"to appoint someone so could it be he or she are used to working for much larger companies and needed the likes Cossèry's input in accepting the job. Indeed I now hope it's Cossèry who lets face it is world class along with Redmile and Vulpes at the business wheel of the Sclp ship charting our course leaving Lindy to do what she does best making cancer her game !!!
aimho
Chelsea11 Vulpes selling ? .....well Diggle felt the sp was derisory at 12p ish why would he sell at 10p unless Vulpes have had enough which I would find unusual that a fund manager would throw his toys out of the pram with a knee jerk reaction to the current situation....aimho